InvestorsHub Logo
Followers 50
Posts 5360
Boards Moderated 0
Alias Born 07/03/2020

Re: attilathehunt post# 283201

Saturday, 11/14/2020 5:06:14 PM

Saturday, November 14, 2020 5:06:14 PM

Post# of 457672
Right. You get to stack the deck. True, it will be useful for a significant fraction of the population rather than all, but I am not aware that drug approvals are available only for panaceas. 2-73 may not be entirely effective for mutated Sigma1 receptors, certain Comt genes,or certain APOE subsets. It may work beautifully in everyone else who doesn't have severe disease.

When Doc compares 2-73 to other drugs, he does not adjust for this. That surprises me in a neurologist who does clinical trials.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News